Transoral Incisionless Fundoplication

DEVICE4 trials

Sponsors

University of Pittsburgh, EndoGastric Solutions, IRCCS San Raffaele, Brigham and Women's Hospital

Conditions

Gastro Esophageal RefluxGastroesophageal Reflux Disease (GERD)Laryngopharyngeal Reflux (LPR)Motility DisorderReflux Disease, Gastro-Esophageal

Phase 3

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

TerminatedNCT00857597

University of PittsburghGastroesophageal Reflux Disease (GERD)

Start: 2009-03-31End: 2011-12-31Updated: 2018-03-30

Unknown Phase

Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study

TerminatedNCT01327963

EndoGastric SolutionsGastroesophageal Reflux Disease (GERD)

Start: 2010-09-30End: 2014-02-28Updated: 2020-12-03

Observational Registry of Transoral Incisionless Fundoplication (TIF) for Gastroesophageal Reflux Disease (GERD)

RecruitingNCT05066594

IRCCS San RaffaeleGastro Esophageal Reflux

Start: 2021-05-01End: 2029-05-31Target: 100Updated: 2021-10-04

Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

WithdrawnNCT05579587

Brigham and Women's HospitalGastroesophageal Reflux Disease (GERD), Laryngopharyngeal Reflux (LPR), Motility Disorder +1

Start: 2024-03-30End: 2025-02-28Updated: 2024-08-05